Xebio Holdings issues stock acquisition rights as stock options

** Xebio Holdings (TSE:8281) announced the specific terms and conditions for issuing stock acquisition rights as stock options to its directors, executive officers, and employees of the Company and its consolidated subsidiaries, approved at the Board of Directors meeting on June 6, 2025. The issuance aims to enhance the Group's business performance, corporate value, and management awareness. A total of 2,500 units of stock acquisition rights will be issued, each entitling the holder to acquire 100 shares of the company’s common stock, totaling 250,000 shares. The rights will be allocated to 3 directors (300 rights), 7 executive officers (1,300 rights) and 47 directors, executive officers, and employees of consolidated subsidiaries (900 rights). The allotment is contingent upon each individual subscribing for at least the number of rights to be allotted. No payment is required in exchange for the stock acquisition rights. The exercise price will be determined by multiplying 1.03 by the average closing price of Xebio's shares on the Tokyo Stock Exchange in the month preceding the allotment date, or the closing price on the allotment date if higher. The allotment date is scheduled for June 13, 2025, and the exercise period will run from June 14, 2027, to June 13, 2032.